Medi Assist Gains Global Investor Backing After INR 578 Cr Stake Sale

The buyers include Citigroup Global Markets Mauritius, Goldman Sachs, Morgan Stanley, and leading domestic mutual funds such as Kotak Mahindra MF, Aditya Birla Sun Life MF, and others.

Medi Assist Healthcare Services has strengthened its shareholder base with the entry of some of the world’s top institutional investors following a ₹577.8 crore block deal.

The transaction involved 15.67% of the company’s equity changing hands on the NSE.

The buyers include Citigroup Global Markets Mauritius, Goldman Sachs, Morgan Stanley, and leading domestic mutual funds such as Kotak Mahindra MF, Aditya Birla Sun Life MF, ICICI Prudential MF, Edelweiss MF, HDFC MF, and Sundaram MF. International players such as PSP Investments (Canada) and Wasatch Global Investors (US) have also joined the stakeholders.

Stronger Institutional Ownership

This shift significantly increases institutional participation in Medi Assist, a change expected to bring more robust governance, better access to capital, and heightened visibility in global markets.

Industry analysts note that such investors typically support companies in scaling operations, pursuing innovation, and entering new markets, areas where Medi Assist is already making strides.

As one of India’s largest third-party administrators (TPAs), Medi Assist serves as a critical link between insurers, hospitals, and policyholders. It enables cashless hospitalization, manages claims, and administers health benefits for millions of customers through partnerships with over 30 insurers and a vast hospital network. The enhanced investor profile could accelerate its plans to expand technology adoption, improve service efficiency, and broaden offerings in preventive health and wellness.

Global Funds Step In as Bessemer Exits Medi Assist

This sale marks the end of Bessemer’s decade-long association with Medi Assist. In September 2024, the private equity firm had already cut down its holding by 13.5% for around ₹580 crore.

Prior to yesterday’s trade, Bessemer still held 15.67%, which has now been fully divested, leaving it with zero promoter holding.

The transaction also reshapes Medi Assist’s shareholding structure. As of the last public filing, the company’s equity was split among promoters (~20.6%), foreign institutional investors (~13.9%), domestic institutions (~42.3%), and public shareholders.

With this deal, institutional ownership, both domestic and foreign, is expected to increase significantly, potentially influencing governance and strategic direction.

Stay tuned for more such updates on Digital Health News